Bingqiang Hu Selected Research

thrombin aptamer

7/2015

Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingqiang Hu Research Topics

Disease

4	Neoplasms (Cancer) 01/2016 - 01/2013
3	Nasopharyngeal Carcinoma 01/2014 - 05/2013
2	Disease Progression 01/2014 - 05/2013
2	Neoplasm Metastasis (Metastasis) 05/2013 - 01/2011
2	Hyperthermia 02/2013 - 01/2011
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Lymphatic Metastasis 05/2013
1	Melanoma (Melanoma, Malignant) 02/2013
1	Breast Neoplasms (Breast Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

2	Codon (Codons)IBA 01/2014 - 05/2013
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 02/2013
2	CytokinesIBA 02/2013 - 01/2011
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	VimentinIBA 01/2016
1	ParaffinIBA 01/2016
1	NucleolinIBA 07/2015
1	AGRO 100IBA 07/2015
1	OligonucleotidesIBA 07/2015
1	thrombin aptamerIBA 07/2015
1	3- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA 07/2015
1	arginylarginine (Arg-Arg)IBA 01/2014
1	prolyl-proline (Pro-Pro)IBA 05/2013
1	Therapeutic UsesIBA 02/2013
1	Peptide Hydrolases (Proteases)FDA Link 02/2013
1	Matrix Metalloproteinases (MMPs)IBA 02/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013
1	Biological ProductsIBA 01/2013

Therapy/Procedure

6	Radiotherapy 01/2016 - 01/2011